Documents
Application Sponsors
| ANDA 212469 | PADAGIS ISRAEL |  | 
Marketing Status
| Prescription | 001 | 
| Prescription | 002 | 
Application Products
| 001 | SPRAY;NASAL | 2.5MG/SPRAY | 0 | ZOLMITRIPTAN | ZOLMITRIPTAN | 
| 002 | SPRAY;NASAL | 5MG/SPRAY | 0 | ZOLMITRIPTAN | ZOLMITRIPTAN | 
FDA Submissions
| UNKNOWN; | ORIG | 1 | AP | 2021-09-30 | STANDARD | 
Submissions Property Types
TE Codes
| 001 | Prescription | AB | 
| 002 | Prescription | AB | 
CDER Filings
PADAGIS ISRAEL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212469
            [companyName] => PADAGIS ISRAEL
            [docInserts] => ["",""]
            [products] => [{"drugName":"ZOLMITRIPTAN","activeIngredients":"ZOLMITRIPTAN","strength":"2.5MG\/SPRAY","dosageForm":"SPRAY;NASAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ZOLMITRIPTAN","activeIngredients":"ZOLMITRIPTAN","strength":"5MG\/SPRAY","dosageForm":"SPRAY;NASAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/30\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-09-30
        )
)